Sb. Yellen et Df. Cella, SOMEONE TO LIVE FOR - SOCIAL WELL-BEING, PARENTHOOD STATUS, AND DECISION-MAKING IN ONCOLOGY, Journal of clinical oncology, 13(5), 1995, pp. 1255-1264
Purpose: Little is known about the influence of social factors on trea
tment preferences and desire for aggressive cancer therapy. The presen
t study assessed subjective and objective social indicators in patient
preferences for treatment. Methods: Cancer patients (N = 296) with di
verse diagnoses and stages read sets of hypothetical vignettes describ
ing patients with early-stage and advanced disease. in the first set,
patients made decisions about treatment acceptance given varying level
s of either increasing cure or extending survival, In the second set,
the point at which patients shifted preferences from mild to severe tr
eatment to improve likelihood of 1-year survival (switch point) was th
e dependent measure, We assessed the impact of quality-of-life (QL) do
mains measured by the Functional Assessment of Cancer Therapy-General
(FACT-G), having children, marital status, and living arrangements on
treatment preferences and switch points. Results: The Social Well-Bein
g (SWB) subscale of the FACT-G predicted both treatment acceptance (P
= .007) and switch point (P = .043) in the advanced-disease vignettes,
with lower SWB associated with less aggressive preferences. Children
living at home was likewise associated with more aggressive intent bot
h in treatment preferences (P = .003, advanced-disease vignette) and s
witch point (P < .001 and P = .001 for early- and advanced-disease vig
nettes, respectively), Living with others predicted more aggressive in
tent in the advanced-disease vignette (P = .03). Marital status did no
t predict either treatment acceptance or switch point. Conclusion: Pos
itive social well-being, as well as having children living at home, pr
edicted patient willingness to accept aggressive treatment, Willingnes
s to receive aggressive treatment may explain or mediate previously re
ported salutory effects of social support on cancer outcomes. (C) 1995
by American Society of Clinical Oncology.